HLB liver cancer drug hits FDA setback again over manufacturing issues

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.

Bethenny Frankel's 5-in-1 Glowy Foundation Is on Sale — But Only for a Few More Hours

Finding a foundation that delivers coverage without looking heavy or cakey is easier said than done. The seemingly endless search is over, thanks to Bethenny Frankel, who reminded Us why she keeps coming back to It Cosmetics CC Cream time and time again. The multitasking formula has earned more than 24,000 five-star reviews on Amazon []

Prime Day Has TikTok-Famous Makeup Finds Starting at Just $5

You don't have to spend a lot on good-quality makeup, because these days, drugstore brands perform just as well as the high-end stuff. And as if drugstore makeup wasn't affordable enough already,...

Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust

Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?

Additional blockbuster drugs may be on the horizon.

Sticker shock has execs rethinking this whole AI thing

This week on The Reg's Kettle podcast, we wonder whether tokenminning is going to bring the industry back down to Earth

A patient got the weight loss medication retatrutide before FDA approval. How does that work?

A primer on retatrutide and compassionate use

Cancer served on a plate? How chemicals banned in Europe are killing Indians

Cancer served on a plate? How chemicals banned in Europe are killing Indians

Experimental drug reverses severe fatty liver disease by repairing the gut

An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.

Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected

Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected

Eli Lilly’s Unapproved Weight-Loss Drug Is Now Sold at Brooklyn Corner Stores for $95

A CBS News reporter purchased Eli Lilly's experimental weight-loss drug retatrutide at a Brooklyn convenience store for 95 with no prescription as toxicity reports rise and the FDA warns such products are of unknown quality and potentially harmful. The drug is currently in clinical trials and has never received regulatory approval.

Syringe services in limbo under Trump, risking hepatitis C progress

WASHINGTON — A decade after Congress first allowed federal funding to support clean needle programs, the Trump administration is backing off that policy, potentially risking progress made against hepatitis C, a deadly but curable virus mostly ...

Is your collagen killing the planet? Inside the dark side of the wellness boom - including donkey skin powder sold on Amazon

Is your collagen killing the planet? Inside the dark side of the wellness boom - including donkey skin powder sold on Amazon

WATCH | Inside South Africa’s illegal weight-loss drug trade 

This week on HealthBeat, the booming market for illegal weight-loss jabs: why are so many people willing to risk them?

‘Absolutely non-negotiable’: The affordable products a dermatologist swears by

Dermatologist Cara McDonald shares the beauty items on her shelf.

Peptides 101: Why gay men are turning to black-market injectables to build muscle

Black market drugs have gone mainstream, creating a billion-dollar peptides industry thanks to society’s unhealthy preoccupation with unrealistic body image, youth, and the expectation that everyone should be thin.

The Supreme Court Just Made It Easier for You to Get Cheaper Generic Drugs—With 1 Major Catch

A ruling in favor of generic drugmaker Hikma will make it harder for brand-name manufacturers to block cheaper alternatives. A pharmaceutical patent lawyer says the legal battle is far from over.

I Tried Lyma’s New ID² Power Gut Bio Complex for a Month—Here’s What Happened

LYMAAll products are selected independently by The Looker’s editors. If you click or purchase something from our post, we may earn a small commission.Lyma, a premium beauty and wellness company with multiple patented products, recently launched ID² Power Gut Bio Complex. According to the brand, this daily, drinkable supplement was developed based on 50 years of longevity research.It promises to “nourish your entire gastrointestinal system” with bioavailable forms of various micronutrients, omega-3s, and four types of prebiotic fiber. But what exactly is Lyma ​​ID², exactly, and is it actually worth its hefty price tag?Read more at The Daily Beast.

Restrictions could be lifted on peptides loved by wellness influencers

Unproven peptides touting wellness have been relegated to a gray market because of Biden-era restrictions. Under the Trump administration, that could change.

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.

Feds Say a Darknet Dealer Called ‘DaddyBiden’ Sold Fake Adderall Laced with Meth

DaddyBiden may have completed more than 10,000 online sales.

Looking for smoother make-up application? This bestselling e.l.f. primer could be worth trying

If your foundation never seems to sit quite right, it may not be because of your make-up at all, you may actually need one more make-up product.

FDA Reviews Sandoz Generic Obesity Drug Applications

The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.

FDA Has Wrong Mission. That's Why It Fails

FDA Has Wrong Mission. That's Why It Fails

US launches investigation into drug prices in Germany, risking renewed tensions with Europe

Donald Trump claims that European healthcare systems, which regulate drug prices, are to blame for the high prices charged by pharmaceutical companies in the US.

Pokémon TCG: Pitch Black Booster Bundle Preorders Are Back in Stock, and Under Market Price

Pokémon TCG: Pitch Black Sealed Booster Bundles preorders are back in stock at Amazon, and while it's not at MSRP, they're still listed for way under market price compared to resale sites like TCGplayer and eBay.

FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal

The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.

One 79-year-old Patient Given Unapproved Powerful Obesity Drug

Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

How a Customer’s Prescription-Counter Meltdown Backfired Into an Immediate Lifetime Ban

The whole situation really just stinks. The post How a Customer’s Prescription-Counter Meltdown Backfired Into an Immediate Lifetime Ban appeared first on TwistedSifter.

Engineered “mini livers” could be injected as an alternative to transplantation

A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blood clotting, removing bacteria from the bloodstream, metabolizing drugs,

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Chinese drug manufacturer with CCP ties imported unauthorized GLP-1 drug ingredients

Federal investigators say that a Chinese drug manufacturer, previously on the Food and Drug Administration’s list of preapproved foreign companies allowed to import GLP-1 ingredients, was able to bring in batches of the weight loss drug from an unauthorized supplier and introduce the substance of unknown origin into the U.S. drug supply. In September 2025, []

Johnson & Johnson (NYSE: JNJ) Shuns $100 Billion GLP-1 Race, Positioning Itself As A Stronger Long-Term Bet Than Eli Lilly (NYSE: LLY)

Johnson Johnson (NYSE: JNJ) is deliberately stepping back from the GLP-1 weight-loss drug market, a sector widely valued at over 100 billion. CEO Joaquin Duato has made clear he has no intention of chasing the weight-loss drug trend, preferring instead to focus on oncology and the company’s sprawling medical device business. The decision stands [] The post Johnson Johnson (NYSE: JNJ) Shuns 100 Billion GLP-1 Race, Positioning Itself As A Stronger Long-Term Bet Than Eli Lilly (NYSE: LLY) appeared first on Foreign Policy Journal.